{"product_id":"soho-artikel44-sar-sae-allvarliga-avvikelser-anmalan-utredning","title":"SoHO Article 44 – SAR\/SAE, notification to authorities, traceability and final report | Word\/PDF\/Excel","description":"\u003csection lang=\"sv\" style=\"color:#183D59;line-height:1.68\"\u003e\n\u003cp\u003e\u003cstrong\u003eHow should a SoHO entity document a suspected serious adverse reaction (SAR) or serious adverse event (SAE) – from discovery to final report?\u003c\/strong\u003e The EU's new human material regulation 2024\/1938 introduces more harmonised obligations for operators handling human material intended for use in humans. This focused template package focuses on \u003cstrong\u003eArticle 44: vigilance, notification to authorities, traceability, recall and investigation\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe rules will mainly start to apply on \u003cstrong\u003e7 August 2027\u003c\/strong\u003e. Before this date, the operator still needs to follow current national rules and prepare for the upcoming requirements. Special transitional rules are found, among others, in Articles 83–84. A SoHO entity or establishment must always investigate what actual role it plays and what material it handles.\u003c\/p\u003e\n\n\u003csection style=\"background:#EDF6FA;border:2px solid #27779D;border-radius:12px;padding:18px;margin:18px 0\"\u003e\u003ch2 style=\"font-size:1.13em;margin:0 0 9px;color:#143C58\"\u003ePackage contents\u003c\/h2\u003e\n\n\u003cp style=\"margin:0\"\u003eFive Swedish operational SAR\/SAE templates and a Swedish user guide, plus an English User Guide. All seven are delivered in editable Word (DOCX) and searchable, printable PDF. In addition, a Swedish Excel register with nine tabs is included. \u003cstrong\u003eTotal of 15 customer files in a digital ZIP.\u003c\/strong\u003e The PDF files lack electronic form fields.\u003c\/p\u003e\u003c\/section\u003e\n\u003csection style=\"background:#EDF6FA;border:2px solid #27779D;border-radius:12px;padding:18px;margin:18px 0\"\u003e\u003ch2 style=\"font-size:1.13em;margin:0 0 9px;color:#143C58\"\u003eWhat the files contain\u003c\/h2\u003e\n\n\u003cp style=\"margin:0\"\u003eInitial SAR\/SAE assessment, initial notification upon suspicion, agreed reporting chain, check of affected human material, traceability and recall, final investigation report, CAPA and check of actual reporting receipts. Excel only handles coded administrative case IDs and statuses – \u003cstrong\u003enot patient records, genetic data or other sensitive health information.\u003c\/strong\u003e\u003c\/p\u003e\u003c\/section\u003e\n\u003ch2\u003eWhat applies according to Article 44?\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle 44.1:\u003c\/strong\u003e A SoHO entity shall have a system to detect, investigate and document adverse reactions and events in relevant SoHO activities.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle 44.3:\u003c\/strong\u003e In case of suspicion of a SAR or SAE that meets the definitions in Articles 3.45–46, the competent authority shall be notified \u003cstrong\u003ewithout undue delay\u003c\/strong\u003e. The initial notification shall include a factual description, a preliminary causality assessment where relevant, protective measures already taken and a preliminary assessment of seriousness. The regulation does not specify a universal fixed 24-hour deadline for all SoHO entities.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle 44.4:\u003c\/strong\u003e Another SoHO entity may need to report the signal to an agreed SoHO establishment or the establishment that supplied the material. Which entity is to investigate and report needs to be assessed based on actual agreements and operational conditions.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle 44.6 and 44.8:\u003c\/strong\u003e There shall be a controllable way to recall human material that is affected or suspected to be affected. Necessary safety information shall be communicated to other affected entities, but only to the relevant and proportionate extent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle 44.7:\u003c\/strong\u003e After an initial report, a separate investigation report shall state the results, final assessment of cause and seriousness, risk of recurrence and corrective\/preventive actions. \u003ca href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1938\/oj\/swe\"\u003eRead the EU regulation on EUR-Lex.\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch2\u003eWhat do you get? – 15 customer files\u003c\/h2\u003e\n\n\u003cdiv style=\"overflow-x:auto\"\u003e\u003ctable style=\"width:100%;min-width:670px;border-collapse:collapse\"\u003e\n\n\u003cthead style=\"background:#173F59;color:#FFFFFF\"\u003e\u003ctr\u003e\n\n\u003cth\u003eDocument\u003c\/th\u003e\n\n\u003cth\u003ePractical purpose\u003c\/th\u003e\n\n\u003cth\u003eLanguage\u003c\/th\u003e\n\n\u003cth\u003eFormat\u003c\/th\u003e\n\n\n\u003c\/tr\u003e\u003c\/thead\u003e\n\n\u003ctbody\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e1. Applicability and initial SAR\/SAE assessment\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDistinguish serious adverse reaction from serious adverse event, classify suspicion and choose the responsible reporting chain.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e2. Initial notification to authorities\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDocument factual information, preliminary causality, protective measures, seriousness and actual transmission receipt.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e3. Traceability, hold and recall\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eTrace coded material references, define the recipient group, stop affected SoHO and follow up on receipts.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e4. Final investigation and CAPA\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eCompile factual cause assessment, consequences, risk of recurrence, corrective and preventive actions.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e5. Contract chain and annual review\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDistinguish agreed entity reporting from authority responsibility and document aggregated annual data.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e6. Swedish user guide\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003ePractical examples, definitions, risk limits, references to Articles 33–44 and GDPR.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"text-align:left;border:1px solid #D9E6EE;padding:10px\"\u003e7. English User Guide\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eEnglish operational instructions for the Swedish templates, not English versions of the Swedish forms.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eEnglish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003cth scope=\"row\" style=\"border:1px solid #D9E6EE;padding:10px;text-align:left\"\u003e8. Excel register with nine tabs\u003c\/th\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eOverview, Events, Assessments, Notifications, Traceability, Recalls, Investigations, Actions, Read me.\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eSwedish\u003c\/td\u003e\n\n\u003ctd style=\"border:1px solid #D9E6EE;padding:10px\"\u003eXLSX\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\n\u003c\/tbody\u003e\n\n\n\u003c\/table\u003e\u003c\/div\u003e\n\n\u003ch2\u003ePractical workflow for SoHO personnel\u003c\/h2\u003e\n\n\u003col\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eProtect immediately:\u003c\/strong\u003e apply the organization's clinical safety, alarm and stop procedures. Filling out documentation must never delay the protection of people.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eRegister the signal:\u003c\/strong\u003e create a coded internal case ID. Document facts and uncertainties without placing patient\/donor identities in a regular Excel file.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eMake an initial SAR\/SAE assessment:\u003c\/strong\u003e distinguish a person's reaction from a process deviation. Assess suspicion of seriousness and which reporting path is applicable.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eReport without undue delay when the obligation applies:\u003c\/strong\u003e use the current official Swedish channel and authority template. Save actual receipt and supplement facts as the investigation progresses.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eTrace affected material:\u003c\/strong\u003e stop distribution or use where necessary, document any recall and reach only the affected actors who need safety information.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eInvestigate and prevent:\u003c\/strong\u003e conduct a root cause investigation, check the risk of recurrence and report actual corrective and preventive actions.\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cstrong\u003eComplete and archive:\u003c\/strong\u003e send the actual final report according to the authority's requirements and ensure that the documentation chain can be recreated without unauthorized dissemination of sensitive information.\u003c\/li\u003e\n\n\n\u003c\/ol\u003e\n\n\u003ch2\u003eExcel: nine tabs and eight administrative metrics\u003c\/h2\u003e\n\n\u003cp\u003eThe register summarizes registered events, assessments marked as SAR\/SAE suspicion, sent initial notifications, open traceability cases, ongoing recalls, registered final reports and open CAPA actions. \u003cstrong\u003eAll eight metrics are 0 upon delivery.\u003c\/strong\u003e The formulas have been tested with fictitious IDs and statuses that were then removed. The statuses are manual work fields: they do \u003cstrong\u003enot\u003c\/strong\u003e determine if a medical condition exists, if something is serious or if the report has been legally fulfilled.\u003c\/p\u003e\n\n\u003ch2\u003eWho is the package suitable for?\u003c\/h2\u003e\n\n\u003cp\u003eOrganizations within blood, blood components, tissues and cells, fertility, relevant human material handling, quality units, clinical safety functions and suppliers with agreed SoHO activities. Before use, the organization must assess whether it is covered by the SoHO regulation, its national obligations, division of responsibility and which existing clinical documentation should be used.\u003c\/p\u003e\n\n\u003ch2\u003eDifference from Mallbutiken's SoHO registration package\u003c\/h2\u003e\n\n\u003cp\u003e\u003ca href=\"\/en\/products\/soho-enhet-2027-registrering-ansvarig-person-qms\"\u003eSoHO entity 2027 – registration, responsible person and quality gap\u003c\/a\u003e focuses on the entity's administrative establishment and overall quality structure. This package instead covers a \u003cstrong\u003econcrete deviation chain according to Article 44\u003c\/strong\u003e, from SAR\/SAE suspicion to notification, traceability, recall and final report. The products have different operational purposes.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eDo the obligations already apply in November 2026?\u003c\/h3\u003e\n\n\u003cp\u003eThe regulation applies as EU law, but most of the operational obligations start to apply on 7 August 2027. Until then, existing Swedish rules and sector-specific obligations also apply. Check explicit exceptions and transitions.\u003c\/p\u003e\n\n\u003ch3\u003eMust a suspicion first be medically confirmed?\u003c\/h3\u003e\n\n\u003cp\u003eNo, Article 44.3 applies to situations where a serious reaction or event is \u003cstrong\u003esuspected\u003c\/strong\u003e. Missing final analysis results should not automatically become a reason to postpone an applicable notification.\u003c\/p\u003e\n\n\u003ch3\u003eDo all SoHO entities have the same reporting recipient?\u003c\/h3\u003e\n\n\u003cp\u003eNo. The reporting chain depends, among other things, on whether the entity performs activities for a SoHO establishment under agreement and on the nationally competent authority. Check actual instructions before reporting.\u003c\/p\u003e\n\n\u003ch3\u003eDo we have to submit the report within 24 hours?\u003c\/h3\u003e\n\n\u003cp\u003eThe EU regulation generally states \u003cstrong\u003ewithout undue delay\u003c\/strong\u003e in Article 44.3, not a general 24-hour deadline. Other applicable national law or special instructions may impose additional requirements.\u003c\/p\u003e\n\n\u003ch3\u003eCan we enter personal numbers and genetic data in Excel?\u003c\/h3\u003e\n\n\u003cp\u003eNo. Use only necessary coded references in the package's workbook. Protected medical records, donor and recipient registers or genetic data should be handled in the organization's authorized system according to data protection rules.\u003c\/p\u003e\n\n\u003ch3\u003eIs 30 June the deadline for each SoHO entity's SAR\/SAE report?\u003c\/h3\u003e\n\n\u003cp\u003eNo. Article 33.13 refers to the authorities' aggregated annual reporting to the EU's SoHO platform. The entity's obligation to notify about a current suspected serious event is governed by Article 44 and current national instructions.\u003c\/p\u003e\n\n\u003ch3\u003eAre these official forms from Socialstyrelsen or IVO?\u003c\/h3\u003e\n\n\u003cp\u003eNo. These are internal working documents. The competent authority and its published reporting channel must be verified for the actual case. No authority contact is made automatically.\u003c\/p\u003e\n\n\u003ch3\u003eIs a complete English version of all work templates included?\u003c\/h3\u003e\n\n\u003cp\u003eNo. Five work templates, Swedish guide and Excel are in Swedish. A separate English User Guide explains the workflow.\u003c\/p\u003e\n\n\u003ch3\u003eIs the product medically or legally certified?\u003c\/h3\u003e\n\n\u003cp\u003eNo. The legal sources have been reviewed with AI assistance on 16 November 2026. No external legal, clinical quality or authority certification has been carried out.\u003c\/p\u003e\n\n\u003ch2\u003eSources and version status\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eVersion 1.0 · AI-assisted legal source check 16 November 2026.\u003c\/strong\u003e Primary sources: \u003ca href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1938\/oj\/swe\"\u003eRegulation (EU) 2024\/1938\u003c\/a\u003e Articles 3, 33, 34, 41 and 44 as well as transitional Articles 83–87; \u003ca href=\"https:\/\/www.lakemedelsverket.se\/sv\/tillstand-godkannande-och-kontroll\/tillverkningstillstand\/tillstand-for-hantering-av-vavnader-och-celler\/forbereda-sig-for-soho-forordningen\"\u003eSwedish Medical Products Agency preparation guidance\u003c\/a\u003e, \u003ca href=\"https:\/\/eur-lex.europa.eu\/eli\/reg_impl\/2025\/1467\/oj\"\u003eEU SoHO platform implementation regulation 2025\/1467\u003c\/a\u003e and \u003ca href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2016\/679\/oj\/swe\"\u003eGDPR\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe files do not replace clinical decision-making, approved quality system, medical record, competent authority reporting form or data protection assessment. National routines and legal situation must be checked upon actual use.\u003c\/p\u003e\n\n\u003c\/section\u003e","brand":"Svenska Dokumentmallar","offers":[{"title":"Default Title","offer_id":56642303951190,"sku":"MB-SOHO-SAR-SAE-20261116-V1","price":79.0,"currency_code":"SEK","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0827\/2373\/3846\/files\/01_Huvudbild_SoHO_SAR_SAE_1600.png?v=1794825289","url":"https:\/\/mallbutiken.se\/en\/products\/soho-artikel44-sar-sae-allvarliga-avvikelser-anmalan-utredning","provider":"Mallbutiken","version":"1.0","type":"link"}